drugset / Trial / NCT01664039
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is evaluate effects of TRAVATAN® versus LUMIGAN® on intraocular pressure (IOP) and ocular surface and inflammatory biomarkers.
Timeline
- Start
- 2012-09
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bimatoprost | Other / unclassified | 0.01 % | Other |
| Subject | Travoprost | Other / unclassified | 0.004 % | Other |